Special Update Meeting: The latest on cell replacement therapies for Parkinson's
A special patient-focused event is scheduled for Thursday 15 May 2025, offering a unique opportunity for participants to engage with researchers in this field. Cure Parkinson’s is supporting the next G-Force PD meeting, an international consortium dedicated to advancing cell replacement therapies for Parkinson’s. This...
Learn more
The 2022 International Linked Clinical Trials meeting
Cure Parkinson’s annually coordinates the International Linked Clinical Trials (iLCT) meeting to rank and prioritise therapies that may have the potential to modify the course of Parkinson’s progression.
Cure Parkinson’s announces new role: Head of Pipeline Research
Cure Parkinson’s is delighted to announce that Dr Leah Mursaleen has been appointed to the newly created role, Head of Pipeline Research. The purpose of this role is to speed up and drive forward early-stage research to ensure that novel treatments for potentially slowing/stopping the…
The 2022 London Marathon raises over £127k for our Parkinson’s research
On Sunday 2 October, 32 Cure Parkinson’s supporters took part in the epic TCS London Marathon, raising £127,000 to help find a cure for Parkinson’s.
2022 Tom Isaacs Award pays tribute to Drs. Michael Okun and Ray Dorsey
Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr Ray Dorsey, University of Rochester, and Dr Michael Okun, University of Florida, are joint winners of the 2022 Tom Isaacs Award.
Professor David K. Simon: new chair of the iLCT Committee
Cure Parkinson’s and Van Andel Institute are delighted to announce that Professor David K. Simon, of Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States has accepted the position as chair of the International Linked Clinical Trials (iLCT) Committee. This prestigious committee…